1982 Chicago Tylenol Murders Litigation Lawsuit

1982 Chicago Tylenol Murders Litigation

The product and manufacturer

Tylenol Extra-Strength capsules were an over-the-counter analgesic containing acetaminophen (paracetamol), manufactured by McNeil, a subsidiary of Johnson & Johnson. The capsules were powder-filled, a form that could be opened and resealed without obvious signs of tampering.

The poisonings

In late September 1982, seven people in the Chicago metropolitan area died after consuming Extra-Strength Tylenol capsules that had been adulterated with potassium cyanide. The first victim was 12-year-old Mary Kellerman, who died on September 29; six others followed from the same area within a day or two, including three members of the Janus family who had taken capsules from a single bottle. Investigators determined that the capsules involved had been manufactured in Pennsylvania and Texas, which indicated the bottles had been tampered with after they reached store shelves. No suspect has ever been charged or convicted of the murders. James Lewis, a New York resident, was convicted of extortion for sending a letter to Johnson & Johnson that claimed responsibility for the deaths and demanded a payment to stop them; later DNA testing did not match him to the bottles, and he maintained his innocence until his death in 2023.

The company response

Johnson & Johnson halted production and advertising of Tylenol, initially recalled the specific lot tied to the first deaths, and then expanded the recall to all Extra-Strength Tylenol capsules purchased in the Chicago area after tainted bottles from other lots were found. On October 5, 1982, the company issued a nationwide recall of all Tylenol products; some 31,000,000 bottles were estimated to have been in circulation. The company offered to exchange purchased capsules for solid tablets and, in November 1982, reintroduced the capsules in a new triple-sealed tamper-resistant package. Its handling of the crisis is still taught as a model of corporate response.

The litigation

The families of the seven victims sued Johnson & Johnson. A separate dispute arose between the manufacturer and its insurer: after the recall, McNeil submitted a claim for the costs of carrying it out, and the claim was denied. Coverage litigation followed, and the matter ultimately ended without coverage, the court reasoning that the recall was not driven by liability for the seven deaths but was, at most, merely related to them.

In 1991, Johnson & Johnson agreed to settle, for an undisclosed amount, all lawsuits against it arising from the original Chicago-area deaths. A company spokesman said the firm wanted to do something for the families and put the event behind it. That settlement resolved the civil claims connected to the 1982 poisonings.

Aftermath

The case reshaped consumer product safety in the United States. The pharmaceutical, food, and consumer goods industries adopted tamper-evident packaging such as induction seals, and the industry moved away from powder-filled capsules toward solid caplet tablets. The FDA issued new anti-tampering regulations, and Congress made product tampering a federal crime. Copycat incidents followed in the 1980s and early 1990s, including a 1986 Excedrin case in which one perpetrator was criminally convicted.

Outcome

The litigation is recorded as resolved by settlement in 1991.